<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1134-8046</journal-id>
<journal-title><![CDATA[Revista de la Sociedad Española del Dolor]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Soc. Esp. Dolor]]></abbrev-journal-title>
<issn>1134-8046</issn>
<publisher>
<publisher-name><![CDATA[Inspira Network Group, S.L ]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1134-80462018000600349</article-id>
<article-id pub-id-type="doi">10.20986/resed.2018.3673/2018</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Recomendaciones basadas en la evidencia para el manejo del dolor neuropático (revisión de la literatura)]]></article-title>
<article-title xml:lang="en"><![CDATA[Evidence-based recommendations for the management of neuropathic pain (review of the literature)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rincón-Carvajal]]></surname>
<given-names><![CDATA[A.-M.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Olaya-Osorio]]></surname>
<given-names><![CDATA[C.-A.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[S.-Martínez]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bernal]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Clínica de Ortopedia y accidente laborales Fundación Santa Fe de Bogotá ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Clínica del Country Unidad de Tratamiento de Dolor (UTD) ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,NeuroEconomix  ]]></institution>
<addr-line><![CDATA[Bogotá ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2018</year>
</pub-date>
<volume>25</volume>
<numero>6</numero>
<fpage>349</fpage>
<lpage>358</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1134-80462018000600349&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1134-80462018000600349&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1134-80462018000600349&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo:  Sintetizar, mediante una revisión de la literatura, las recomendaciones actuales en el manejo del dolor neuropático.  Metodología:  Revisión temática basada en una búsqueda de literatura altamente sensible para la identificación de guías de práctica clínica y revisiones sistémicas de la literatura enfocadas en diagnóstico y manejo del dolor neuropático, desde 2012 a 2017. De las referencias incluidas, se obtuvo información relacionada con definiciones, consideraciones relevantes, indicaciones y objetivos del tratamiento, tanto farmacológico como no farmacológico y criterios de remisión.  Resultados:  Se incluyeron 34 guías de práctica clínica relevantes para el manejo del dolor neuropático. Se realizó una síntesis de aspectos relevantes enfocados en: 1) las herramientas de tamización disponibles para la identificación y clasificación del dolor neuropático; 2) el diagnóstico y seguimiento de las pruebas de confirmación; 3) principios del manejo del dolor, así como el manejo farmacológico y no farmacológico de primera, segunda y tercera línea, de acuerdo con la localización de las lesiones; y 4) seguimiento. Los tratamientos de primera línea más comúnmente recomendados influyen los antidepresivos tricíclicos, &#945;2&#948;-ligandos (pregabalina y gabapentina) y los inhibidores selectivos de la recaptación de serotonina/noradrenalina.  Conclusión:  El dolor neuropático es una condición común en la práctica clínica, donde el médico no especialista en dolor realizará el diagnóstico basado en una historia clínica detallada y examen físico dirigido. El tratamiento debe ser multidisciplinario e iniciarse precozmente con fármacos de primera línea.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objective:  To synthesize, through a literature review, the current recommendations in the management of neuropathic pain.  Methodology:  Thematic review based on a highly sensitive literature search for the identification of clinical practice guidelines and systematic reviews, focused on diagnosis and management of neuropathic pain, from 2012 to 2017. From the included references, it was obtained information related to definitions, relevant considerations, indications and objectives of treatment, both pharmacological and non-pharmacological, as well as remission criteria.  Results:  We included 34 relevant clinical practice guidelines for the management of neuropathic pain. The synthesis of relevant aspects focused on: 1) the screening tools available for identification and classification of neuropathic pain; 2) diagnosis and follow-up of confirmation tests; 3) pain management principles, as well as pharmacological and non-pharmacological management as first, second and third line, according to the location of lesions; and 4) follow-up. The most commonly recommended first-line treatments include tricyclic antidepressants, &#945;2&#948;-ligands (pregabalin and gabapentin), and selective serotonin / noradrenaline reuptake inhibitors.  Conclusion:  Neuropathic pain is a common condition in clinical practice, where the non-pain specialist will perform the diagnosis based on a detailed clinical history and directed physical exam. The treatment must be multidisciplinary and begin early with first-line drugs.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Pain management]]></kwd>
<kwd lng="en"><![CDATA[neuralgia (MeSH)]]></kwd>
<kwd lng="en"><![CDATA[therapeutics (MeSH)]]></kwd>
<kwd lng="en"><![CDATA[practice guidelines as topic (MeSH)]]></kwd>
<kwd lng="en"><![CDATA[somatosensorial system]]></kwd>
<kwd lng="es"><![CDATA[Manejo del dolor]]></kwd>
<kwd lng="es"><![CDATA[neuralgia (DeCS)]]></kwd>
<kwd lng="es"><![CDATA[terapéutica (DeCS)]]></kwd>
<kwd lng="es"><![CDATA[guías de práctica clínica como asunto (DeCS)]]></kwd>
<kwd lng="es"><![CDATA[sistema somatosensorial]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical practice guidelines for management of neuropathic pain expert panel recommendations for South Africa]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chetty]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Baalbergen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bhigjee]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kamerman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ouma]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Raath]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[SAMJ South Afr Med J]]></source>
<year>2012</year>
<volume>102</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>312-25</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neuropathic pain in the community more under-treated than refractory?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torrance]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Ferguson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Afolabi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Serpell]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain]]></source>
<year>2013</year>
<volume>154</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>690-9</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neuropathic pain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colloca]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ludman]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bouhassira]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dickenson]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Yarnitsky]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Nat Rev Dis Primer]]></source>
<year>2017</year>
<volume>3</volume>
<page-range>17002</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Managing chronic pain in the non-specialist setting a new SIGN guideline]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Hardman]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Stein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Colvin]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Gen Pr]]></source>
<year>2014</year>
<volume>64</volume>
<numero>624</numero>
<issue>624</issue>
<page-range>e462-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<collab>The National Institute for Health and Care Excellence</collab>
<source><![CDATA[Neuropathic pain in adults: pharmacological management in non-specialist settings | Guidance and guidelines | NICE]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dolor neuropático, clasificación y estrategias de manejo para médicos generales]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Correa-Illanes]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Médica Clínica Las Condes]]></source>
<year>2014</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>189-99</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[An epidemiological study of neuropathic pain symptoms in Canadian adults]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[VanDenKerkhof]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Mann]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Torrance]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gilron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain Res Manag]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dworkin]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Interventional management of neuropathic pain NeuPSIG recommendations]]></article-title>
<collab>O'Connor AB.Kent J.Mackey SC.Raja SN.Stacey BR</collab>
<source><![CDATA[Pain]]></source>
<year>2013</year>
<volume>154</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2249-61</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Most Relevant Neuropathic Pain Treatment and Chronic Low Back Pain Management Guidelines A Change Pain Latin America Advisory Panel Consensus]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amescua-García]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Colimon]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Jreige Iskandar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Berenguel Cook]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bonilla]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain Med]]></source>
<year>2018</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>460-70</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canós Verdecho]]></surname>
<given-names><![CDATA[MÁ]]></given-names>
</name>
<name>
<surname><![CDATA[Llona]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Barrés Carsí]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ibor Vidal]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Diagnóstico y tratamiento del dolor neuropático periférico y localizado]]></source>
<year>2017</year>
<publisher-name><![CDATA[Sociedad Española de Médicos de Atención Primaria (SEMERGEN)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence of French GPs to chronic neuropathic pain clinical guidelines Results of a cross-sectional, randomized,"e" case-vignette survey]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Attal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Vanzo]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Vicaut]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gautier]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Bouhassira]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[PloS One]]></source>
<year>2014</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e93855</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="">
<collab>Canadian Agency for Drugs and Technologies in Health</collab>
<source><![CDATA[Diagnostic Methods for Neuropathic Pain: A Review of Diagnostic Accuracy]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[What is localized neuropathic pain A first proposal to characterize and define a widely used term]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mick]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Finnerup]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Hans]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kern]]></surname>
<given-names><![CDATA[KU]]></given-names>
</name>
<name>
<surname><![CDATA[Brett]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain]]></source>
<year>2012</year>
<volume>2</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>71-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment focus on 5% lidocaine-medicated plaster]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casale]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mattia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Ther Clin Risk Manag]]></source>
<year>2014</year>
<volume>10</volume>
<page-range>259</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Dolor neuropático localizado, conceptualización y manejo en la práctica médica general: consenso de un grupo de expertos]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pasternak]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Chehab]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Orellana]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Iberoam Dolor]]></source>
<year>2010</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Neuropathic pain an updated grading system for research and clinical practice]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Finnerup]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Haroutounian]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kamerman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bennett]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Bouhassira]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain]]></source>
<year>2016</year>
<volume>157</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1599-606</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Allodynia and hyperalgesia in neuropathic pain clinical manifestations and mechanisms]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jensen]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Finnerup]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Neurol]]></source>
<year>2014</year>
<volume>13</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>924-35</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Nerve conduction studies and electromyography in the evaluation of peripheral nerve injuries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Quan]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bird]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Univ Pa Orthop J]]></source>
<year>1999</year>
<volume>12</volume>
<page-range>45-51</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacological management of chronic neuropathic pain revised consensus statement from the Canadian Pain Society]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moulin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Boulanger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Dao]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Finley]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<source><![CDATA[Pain Res Manage]]></source>
<year>2014</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>328-35</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Antidepressants and gabapentinoids in neuropathic pain Mechanistic insights]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kremer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salvat]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Muller]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yalcin]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Barrot]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuroscience]]></source>
<year>2016</year>
<volume>338</volume>
<page-range>183-206</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Acevedo]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for the diagnosis and management of neuropathic pain consensus of a group of Latin American experts]]></article-title>
<collab>Casasola O de L.Chinchilla N.De Giorgis M.Flórez S</collab>
<source><![CDATA[J Pain Palliat Care Pharmacother]]></source>
<year>2009</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>261-81</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flórez Beledo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Farmacología clínica]]></source>
<year>2014</year>
<edition>6</edition>
<publisher-name><![CDATA[Elsevier Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tapentadol vs pregabalina asociada a otros opioides en dolor crónico: análisis de coste-efectividad]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Avellanal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz-Reganon]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Orts]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Soc Esp Dolor]]></source>
<year>2014</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>84-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Topical Treatments for Localized Neuropathic Pain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casale]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Symeonidou]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Bartolo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Pain Headache Rep]]></source>
<year>2017</year>
<volume>21</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>15</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Localized neuropathic pain an expert consensus on local treatments]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pickering]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Tiberghien]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Delorme]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mick]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Drug Des Devel Ther]]></source>
<year>2017</year>
<volume>11</volume>
<page-range>2709-18</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A pharmacological treatment algorithm for localized neuropathic pain]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allegri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hans]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Correa-Illanes]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mayoral Rojals]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Mick]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Curr Med Res Opin]]></source>
<year>2016</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>377-84</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The topical 5 % lidocaine medicated plaster in localized neuropathic pain a reappraisal of the clinical evidence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[de León-Casasola]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Mayoral]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<source><![CDATA[J Pain Res]]></source>
<year>2016</year>
<volume>9</volume>
<page-range>67</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP) a randomised, double-blind, placebo-controlled trial]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Attal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[de Andrade]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Adam]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ranoux]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Galhardoni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Neurol]]></source>
<year>2016</year>
<volume>15</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>555-65</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento del dolor neuropático. Revisión de las últimas guías y recomendaciones]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rey]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Neurol Argent]]></source>
<year>2013</year>
<volume>5</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento del dolor neuropático central; futuras terapias analgésicas revisión sistemática]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora Moscoso]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán Ruiz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soriano Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alba-Moreno de]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Soc Esp Dolor]]></source>
<year>2014</year>
<volume>21</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>270-80</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Agentes físicos superficiales y dolor análisis de su eficacia a la luz de la evidencia científica]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavez Ulloa]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Soc Esp Dolor]]></source>
<year>2009</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>182-9</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mailis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taenzer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence-based guideline for neuropathic pain interventional treatments Spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks]]></article-title>
<collab>Canadian Pain Society</collab>
<source><![CDATA[Pain Res Manage]]></source>
<year>2012</year>
<volume>17</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>150-8</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Síndrome doloroso regional complejo]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cuenca González]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Flores Torres]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Méndez Saavedra]]></surname>
<given-names><![CDATA[KV]]></given-names>
</name>
<name>
<surname><![CDATA[Barca Fernández]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Alcina Navarro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Villena Ferrer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Clínica Med Fam]]></source>
<year>2012</year>
<volume>5</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>120-9</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacotherapy for neuropathic pain in adults a systematic review and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Finnerup]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Attal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Haroutounian]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McNicol]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Baron]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dworkin]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet Neurol]]></source>
<year>2015</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>162-73</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
